| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Actin-related protein 2/3 complex subunit 5;Arp2/3 complex 16 kDa subunit;p16-ARC;ARPC5;ARC16; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Form | Liquid |
| Host | |
| Immunogen | A synthesized peptide derived from human CRKL |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Storage | |
| Target | |
| UniProt # |
Overview
This product is an anti-CRKL antibody for target detection and characterization. Key identifiers include host species: Rabbit; Monoclonal; clone 23C70; isotype IgG; reactivity: Human. Reported application contexts include WB, IHC, ICC, IF (as provided in the source record). Boster Bio Anti-CRKL Rabbit Monoclonal Antibody catalog # M02100-1. Tested in WB, IHC, ICC/IF applications. This antibody reacts with Human.
Key elements and design rationale
- Target: CRKL (Actin-related protein 2/3 complex subunit 5).
- Antibody format: Monoclonal; clone 23C70; isotype IgG.
- Host: Rabbit.
- Species reactivity: Human (confirm in your model system with appropriate controls).
This description is intended to help interpret the antibody design and the biological context of the target using the fields provided in the catalog record, alongside general experimental considerations.
Biological background
CRKL (protein: Lysosome-associated membrane glycoprotein 2 (Lamp2)) is a commonly studied target in molecular and cellular biology. Functional context (as provided): Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Reported cellular localization context: Cytoplasm, cytoskeleton . Cell projection . Tissue expression notes (as provided): Predominantly in urogenital tissues.
Research relevance and current trends
- Research context keywords from the source record include: Cancer,Epigenetics and Nuclear Signaling,Nuclear Import/Export,Protein Trafficking,Signal Transduction,Transcription,Tumor Biomarkers.
- Current studies often focus on connecting target abundance/localization to pathway perturbations across models, tissues, and cell states.
- Quantitative and multiplexed assays (e.g., imaging + immunoblot panels) are commonly used to compare phenotypes across conditions and time-courses.
Common research applications
- Western blotting (WB): assess relative target abundance across samples, treatments, or time-points.
- Immunohistochemistry (IHC): evaluate spatial distribution of target-positive staining in tissue architecture.
- Immunofluorescence/ICC (IF/ICC): visualize subcellular localization patterns and cell-to-cell heterogeneity.
Workflow ideas (metafield): Validate CRKL antibody specificity using KO/KD control samples (WB/IF/IHC as appropriate), Detect CRKL expression by Western blot in cell or tissue lysates, Detect CRKL in FFPE tissue sections by immunohistochemistry, Localize CRKL by immunofluorescence/immunocytochemistry in cultured cells
Notes for experimental interpretation
- Consider isoforms and post-translational modifications (PTMs) that may shift apparent molecular weight or epitope accessibility.
- Apparent molecular weight may vary by sample type and processing (observed MW: 39 kDa; calculated MW: 16320 MW).
- Control concepts: include appropriate negative controls (e.g., isotype, KO/KD samples) and orthogonal validation when feasible.
Additional product details (from the source record)
- Molecular weight (observed): 39 kDa
- Cellular localization (provided): Cytoplasm, cytoskeleton . Cell projection .
- Tissue details (provided): Predominantly in urogenital tissues.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
